Molnlycke Health Care Commends FDA for Proposed Ban on Most Powdered Medical Gloves

Mölnlycke Health Care commends the Food and Drug Administration (FDA) for its proposed ban on most powdered medical gloves due to safety concerns for healthcare providers, patients and others who may be exposed to them. Powdered gloves can cause postoperative adhesions, granulomas, delayed wound healing, increased risk of infection and occupational asthma.

Mölnlycke Health Care, the manufacturer of Biogel® surgical gloves, is the world’s first and only major powder-free surgical glove manufacturer. For more than 30 years, the proprietary Biogel coating has made donning surgical gloves easier, eliminating the need for glove powder. Since their introduction, Biogel gloves have continued to set the industry standard for surgical glove quality with a wide range of natural rubber latex and synthetic options for various clinical applications. Nine out of 10 surgeons surveyed agree that Biogel gloves provide the high quality they need for surgery.2

”Patients, healthcare providers and hospitals are at the heart of everything we do at Mölnlycke Health Care,” says Rob Rayl, president of Mölnlycke Health Care’s US business. ”Their safety is always our primary concern. It is our privilege to provide products such as our Biogel gloves that protect them, offer value and are supported by clinical and health economic evidence. We are hopeful the ban on most powdered gloves, including powdered surgical gloves, will be finalized following the 90-day public comment period.”

Source: Mölnlycke Health Care